Opportunity Information: Apply for RFA MH 20 305
The grant opportunity "Addressing Suicide Research Gaps: Understanding Mortality Outcomes (R01 Clinical Trial Not Allowed)" (RFA-MH-20-305) is a National Institutes of Health (NIH) funding announcement that supports research aimed at closing key knowledge gaps about suicide mortality outcomes by making better use of data that already exist. Rather than funding new clinical trials, the FOA is centered on secondary analyses and data integration, meaning investigators are expected to leverage and combine existing sources such as prior basic science, clinical, and intervention studies on suicide risk and suicidal behaviors, along with real-world data streams like healthcare records and social media data. The core goal is to generate new insights into what predicts suicide death and what factors may change risk across individuals or contexts, using innovative analytic approaches on already-collected information.
A major emphasis of this FOA is identifying predictors and moderators of suicide risk, particularly those tied to mortality outcomes. Predictors can include biological variables (for example, biomarkers or physiological indicators), experiential and environmental factors (such as trauma exposure, life stressors, or social determinants), and other measurable characteristics that may signal heightened risk. Moderators are factors that influence the strength or direction of those relationships, helping explain why certain predictors matter more for some people than others, or under certain circumstances. The announcement explicitly encourages dimensional variables, which typically means measuring traits, symptoms, or behaviors along continuous scales rather than as simple yes/no categories. It also encourages multi-level analyses, which can involve integrating information across different layers such as biology, behavior, clinical presentation, social context, and system-level factors like healthcare access and service use.
Because this is an R01 mechanism, the intent is to support substantial, well-scoped research projects with strong scientific rigor, clear hypotheses, and robust analytic plans. The "Clinical Trial Not Allowed" designation is important: applications should not propose prospective interventional studies that assign participants to conditions to test health outcomes. Instead, the work should focus on secondary data analysis, harmonization of variables across datasets, linkage of datasets (where permitted and feasible), and advanced modeling approaches to better understand pathways to suicide mortality. Projects that can responsibly connect different data types (for instance, clinical histories with digital traces or administrative health outcomes) fit especially well with the FOA's focus on leveraging existing resources to answer questions that single datasets cannot address alone.
Eligibility is broad and includes many types of organizations that can contribute to suicide research infrastructure and analysis. Applicants may include state, county, city, township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized tribal governments; public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status (outside higher education); for-profit organizations (other than small businesses); and small businesses, among others. The FOA also highlights additional eligible applicant categories, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and even non-U.S. entities (foreign organizations), reflecting an interest in diverse institutional participation and potentially broader data resources.
Key administrative details from the source listing include that the opportunity is discretionary and uses a grant funding instrument under the health activity category, with CFDA number 93.242. The original closing date listed is February 10, 2020, with a stated award ceiling of $500,000. The listing does not specify the number of expected awards in the provided text. Overall, the program is designed to accelerate progress by encouraging researchers to combine and reanalyze existing datasets in sophisticated ways to uncover actionable, multi-dimensional indicators of suicide mortality risk, with the ultimate aim of improving understanding that can inform prevention strategies and future research directions without conducting new clinical trials under this specific mechanism.Apply for RFA MH 20 305
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Addressing Suicide Research Gaps: Understanding Mortality Outcomes (R01 Clinical Trial Not Allowed )" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242.
- This funding opportunity was created on 2019-11-20.
- Applicants must submit their applications by 2020-02-10. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed)
Previous opportunity: Youth Empowerment Activity
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA MH 20 305
Applicants also applied for:
Applicants who have applied for this opportunity (RFA MH 20 305) also looked into and applied for these:
| Funding Opportunity |
|---|
| Institutional Training for a Dental, Oral and Craniofacial Research Workforce (T90/R90 Clinical Trial Not Allowed) Apply for PAR 20 056 Funding Number: PAR 20 056 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Training for a Dental, Oral and Craniofacial Research Workforce (T32 Clinical Trial Not Allowed) Apply for PAR 20 044 Funding Number: PAR 20 044 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional) Apply for RFA MH 20 350 Funding Number: RFA MH 20 350 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional) Apply for RFA MH 20 351 Funding Number: RFA MH 20 351 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed) Apply for PAR 20 063 Funding Number: PAR 20 063 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| 4DN Organization and Function in Human Health and Disease (U01 Clinical Trial Not Allowed) Apply for RFA RM 20 005 Funding Number: RFA RM 20 005 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Practice-Based Research for Implementing Scalable Evidence-Based Prevention Interventions in Primary Care Settings (R01 Clinical Trial Optional) Apply for RFA MH 20 505 Funding Number: RFA MH 20 505 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| New Investigator Projects on 4DN Organization and Function in Human Health and Disease (U01 Clinical Trial Not Allowed) Apply for RFA RM 20 006 Funding Number: RFA RM 20 006 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Implementation Research in HRSA Ryan White Sites: Screening and Treatment for Mental and Substance Use Disorders to Further the National Ending the HIV Epidemic (EHE) Goals (R01 Clinical Trial Optional) Apply for RFA MH 20 520 Funding Number: RFA MH 20 520 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Implementation Research in HRSA Ryan White Sites: Screening and Treatment for Mental and Substance Use Disorders to Further the National Ending the HIV Epidemic (EHE) Goals (R34 Clinical Trial Optional) Apply for RFA MH 20 521 Funding Number: RFA MH 20 521 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Practice-Based Research for Implementing Scalable Evidence-Based Prevention Interventions in Primary Care Settings (R34 Clinical Trial Required) Apply for RFA MH 20 506 Funding Number: RFA MH 20 506 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Real Time Chromatin Dynamics and Function (U01 Clinical Trial Not Allowed) Apply for RFA RM 20 003 Funding Number: RFA RM 20 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| 4DN Centers for Data Integration, Modeling and Visualization (UM1 Clinical Trial Not Allowed) Apply for RFA RM 20 004 Funding Number: RFA RM 20 004 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIMH Instrumentation Program (S10 Clinical Trial Not Allowed) Apply for RFA MH 20 555 Funding Number: RFA MH 20 555 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Fine-Mapping Genome-Wide Associated Loci to Identify Proximate Causal Mechanisms of Serious Mental Illness (R01 Clinical Trial Not Allowed) Apply for RFA MH 21 100 Funding Number: RFA MH 21 100 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Implementing and Sustaining Evidence-Based Mental Health Practices in Low-Resource Settings to Achieve Equity in Outcomes (R34 Clinical Trial Required ) Apply for RFA MH 20 401 Funding Number: RFA MH 20 401 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Clinical High Risk for Psychosis Research Network (U01 Clinical Trial Not Allowed) Apply for RFA MH 20 340 Funding Number: RFA MH 20 340 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Effectiveness of Implementing Sustainable Evidence-Based Mental Health Practices in Low-Resource Settings to Achieve Mental Health Equity for Traditionally Underserved Populations (R01 Clinical Trial Optional) Apply for RFA MH 20 400 Funding Number: RFA MH 20 400 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Postbaccalaureate Research Education Program (R25 - Independent Clinical Trial Not Allowed) Apply for PAR 20 066 Funding Number: PAR 20 066 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Transformative Technology Development for the Human BioMolecular Atlas Program (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA RM 20 001 Funding Number: RFA RM 20 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA MH 20 305", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
